High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo-Reference-Cited by-同舟云学术

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

Published:2009-11-13 Issue:1 Volume:9 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Lehmann Annika,Denkert Carsten,Budczies Jan,Buckendahl Ann-Christin,Darb-Esfahani Silvia,Noske Aurelia,Müller Berit Maria,Bahra Marcus,Neuhaus Peter,Dietel Manfred,Kristiansen Glen,Weichert Wilko

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-9-395/fulltext.html

Reference33 articles.

1. Richards EJ, Elgin SCR: Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell. 2002, 108: 489-500. 10.1016/S0092-8674(02)00644-X.

2. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK: Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001, 1: 194-202. 10.1038/35106079.

3. Xu WS, Parmigiani RB, Marks PA: Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007, 26: 5541-5552. 10.1038/sj.onc.1210620.

4. de Ruijter AJM, van Gennip AH, Caron HN, Kemp S, van Kuilenburg ABP: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003, 370: 737-749. 10.1042/BJ20021321.

5. Timmermann S, Lehrmann H, Polesskaya A, Harel-Bellan A: Histone acetylation and disease. Cell Mol Life Sci. 2001, 58: 728-736. 10.1007/PL00000896.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes;International Journal of Oncology;2024-01-16

2. Epigenetic therapeutic strategies in pancreatic cancer;International Review of Cell and Molecular Biology;2024

3. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression;Nature Communications;2023-12-06

4. Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression;2023-09-14

5. Epigenetic control of pancreatic cancer metastasis;Cancer and Metastasis Reviews;2023-09-02